Oliver Homann Selected Research

Oliver Homann Research Topics

4	Neoplasms (Cancer) 03/2022 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2016
1	Obesity 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Non-alcoholic Fatty Liver Disease 10/2021
1	Bites and Stings (Sting) 03/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2021
1	Necrosis 01/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Leukemia 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2016

1	Ligases (Synthetase)IBA 03/2022
1	UbiquitinIBA 03/2022
1	Proteolysis Targeting ChimeraIBA 03/2022
1	Lipoprotein(a)IBA 01/2022
1	Phospholipases (Phospholipase)IBA 10/2021
1	Small Interfering RNA (siRNA)IBA 10/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	Bispecific AntibodiesIBA 03/2021
1	blinatumomabIBA 03/2021
1	AMG 757IBA 01/2021
1	LigandsIBA 01/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Niclosamide FDA Link 01/2019
1	nitazoxanide (NTZ)FDA Link 01/2019
1	Islet Amyloid PolypeptideIBA 01/2016
1	Aspartic Acid ProteasesIBA 01/2016
1	Amyloid (Amyloid Fibrils)IBA 01/2016
1	EnzymesIBA 01/2016